Freyja Healthcare Secures FDA Clearance for Innovative VereSee Mini Laparoscope Visualization System

Freyja Healthcare has officially received U.S. Food and Drug Administration 510(k) clearance for its second-generation VereSee™ Mini Laparoscope, featuring the pioneering VisualEntry™ System. This milestone marks a significant shift in minimally invasive surgery by prioritizing visual confirmation during the critical initial abdominal access phase. By integrating high-quality imaging directly into the entry process, the technology addresses a fundamental safety gap in current surgical protocols.

The VereSee system is engineered to provide surgeons with immediate anatomical visualization, potentially eliminating the need for additional equipment during routine procedures. Its design combines single-use entry components with reusable visualization technology, striking a balance between clinical efficiency and healthcare economics. This platform-based approach ensures seamless integration into existing hospital and ambulatory surgical workflows while maintaining high standards of patient care.

As the company begins commercial distribution, the medical community anticipates that VereSee will redefine standards for laparoscopic entry. Founder Dr. Jon I. Einarsson emphasizes that the system offers surgeons a transformative way to view anatomy from the very start of a procedure. This innovation represents a major step forward in the miniaturization of surgical tools, ultimately enhancing procedural precision and outcomes for patients undergoing minimally invasive interventions.